The impact of ethnicity on treatment and engagement with mental health services is well documented. John Baker’s recent Mental Elf post highlights the damning evidence behind murmurs of institutional racism within the NHS that just won’t go away: certain ethnic groups consistently experience lower quality care and poor outcomes across a wide range of health [read the full story…]
Some of the elves in our neck of the woods like to go on a trip to Mushroom Kingdom from time to time, just to relax and boost their abilities you understand. Unfortunately being able to double in size or become invincible hasn’t happened in real life yet, but a recent study has looked at [read the full story…]
Major depressive disorder (MDD) is unfortunately a relatively common condition in children and adolescents. Depression is estimated to affect 2% of pre-pubertal children and 5-8% of adolescents (Son et al, 2000). As you might expect, depression has a significant negative impact on the development, functioning and risk for suicide in individuals affected, as well as [read the full story…]
In addition to its impact on quality of life, panic disorder can have a number of costly consequences such as lost productivity – particularly if also associated with agoraphobia. Cost-effectiveness is therefore an important consideration in choosing the optimal treatment for panic disorder, which might improve value via the cost side of the equation. A recent [read the full story…]
Approximately 10.6% of individuals with Substance Use Disorders (SUD) in the US seek treatment, with 40-60% relapsing within a year (Dept of Health and Human Services, 2008; McLellan et al, 2000). This highlights a real need for substance abuse treatment that focuses on relapse prevention. This blog summarises a recent RCT from JAMA Psychiatry on [read the full story…]
For many years, psychiatry has highlighted that people with epilepsy appear to have an elevated risk for psychosis. However, studies exploring this relationship (of which there are many) seem to disagree on just what the prevalence of psychosis is in this group. For example, Gudmundsson (1966) interviewed every patient with epilepsy in Iceland and concluded [read the full story…]
Anorexia Nervosa (AN) is a very serious illness with a high morbidity; it is also notoriously difficult to treat. Praise then to researchers investigating innovative treatments that might help. This pair of papers investigating the hormone oxytocin have been widely reported in the popular press, from the BBC to Time magazine and the Daily Mail (link withheld [read the full story…]
Is it possible to work out which of two adolescents sitting before you complaining of unhappiness, which one will go home and sleep it off and which will go on to develop an episode of major depression? Has the biological revolution in psychiatry finally come to fruition with a useful biomarker for making treatment decisions? [read the full story…]
If a treatment is powerful enough to have a good effect, then it’s powerful enough to have a bad effect. This is well recognised when it comes to medication, with strict regulations in place to ensure adverse outcomes are monitored and measured. By contrast, psychotherapy has never been as readily associated with the potential to [read the full story…]
Social functioning is defined as the degree to which a person is able to fulfill different roles in social environments, such as home, work or relationships (Bosc, 2000). There is consistent evidence that depressed patients display considerable social functioning impairments, which add significantly to the burden of depression. In a recent article published in Psychological [read the full story…]
